Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
---, Klinik für Frauenheilkunde und Geburtshilfe
Aktuelle Veranstaltungen
Vergangene Veranstaltungen (max. 10)
-
2022 WS
-
2022 SS
-
2021 WS
-
2021 SS
-
2020 WS
-
2020 SS
-
2019 WS
-
2019 SS
-
2018 WS
-
2018 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Correlation between Imaging Markers Derived from PET/MRI and Invasive Acquired Biomarkers in Newly Diagnosed Breast CancerIn: Cancers Jg. 15 (2023) Nr. 6,ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access)
-
Combinatorial Power of cfDNA, CTCs and EVs in OncologyIn: Diagnostics Jg. 12 (2022) Nr. 4, S. 870ISSN: 2075-4418Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Detection of ESR1 Mutations in Primary Tumors and Plasma Cell-Free DNA in High-Grade Serous Ovarian Carcinoma PatientsIn: Cancers Jg. 14 (2022) Nr. 15,ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access)
-
In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor CellsIn: Cancers Jg. 14 (2022) Nr. 14,ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Multimodality in liquid biopsy : does a combination uncover insights undetectable in individual blood analytes?In: Journal of Laboratory Medicine Jg. 46 (2022) Nr. 4, S. 255 - 264ISSN: 0342-3026; 1439-0477Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic significance of SLFN11 methylation in plasma cell-free dna in advanced high-grade serous ovarian cancerIn: Cancers Jg. 14 (2022) Nr. 1,ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access)
-
Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapseIn: Journal of Cancer Research and Clinical Oncology (2022) in pressISSN: 1432-1335; 0171-5216; 0084-5353; 0301-1585Online Volltext: dx.doi.org/ (Open Access)
-
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflowIn: Breast Cancer: The Journal of the Japanese Breast Cancer Society Jg. 29 (2022) Nr. 3, S. 487 - 497ISSN: 1340-6868; 1880-4233Online Volltext: dx.doi.org/ (Open Access)
-
Systematic Evaluation of HLA-G 3’Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients : UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease OutcomeIn: Frontiers in Immunology Jg. 12 (2022)ISSN: 1664-3224Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
An observational study on breast cancer survival and lifestyle related risk factorsIn: In Vivo Jg. 35 (2021) Nr. 2, S. 1007 - 1015ISSN: 1791-7549; 0258-851XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Association of Soluble B7-H4 and Circulating Tumor Cells in Blood of Advanced Epithelial Ovarian Cancer PatientsIn: Frontiers in Oncology Jg. 11 (2021)ISSN: 2234-943XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Disseminated tumour cells from the bone marrow of early breast cancer patients : Results from an international pooled analysisIn: European Journal of Cancer (EJC) Jg. 154 (2021) S. 128 - 137ISSN: 1879-0852; 0959-8049; 1879-2995Online Volltext: dx.doi.org/
-
Image-based identification and genomic analysis of single circulating tumor cells in high grade serous ovarian cancer patientsIn: Cancers Jg. 13 (2021) Nr. 15,ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancerIn: Genome Medicine Jg. 13 (2021) Nr. 1,ISSN: 1756-994XOnline Volltext: dx.doi.org/ (Open Access)
-
Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer PatientsIn: Cells Jg. 10 (2021) Nr. 2, S. 212ISSN: 2073-4409Online Volltext: dx.doi.org/ (Open Access)
-
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancerIn: Journal of Cancer Research and Clinical Oncology (2021) in pressISSN: 1432-1335; 0171-5216; 0084-5353; 0301-1585Online Volltext: dx.doi.org/ (Open Access)
-
6-Color/1-Target Immuno-SERS Microscopy on the Same Single Cancer CellIn: ACS Applied Materials & Interfaces Jg. 12 (2020) Nr. 29, S. 32321 - 32327ISSN: 1944-8252; 1944-8244Online Volltext: dx.doi.org/ (Open Access)
-
A proposal for score assignment to characterize biological processes from mass spectral analysis of serumIn: Clinical Mass Spectrometry Jg. 18 (2020) S. 13 - 26ISSN: 2376-9998Online Volltext: dx.doi.org/ (Open Access)
-
CXCR4 and JUNB double-positive disseminated tumor cells are detected frequently in breast cancer patients at primary diagnosisIn: Therapeutic Advances in Medical Oncology Jg. 12 (2020)ISSN: 1758-8359; 1758-8340Online Volltext: dx.doi.org/ (Open Access)
-
Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast CancerIn: Frontiers in Oncology Jg. 10 (2020) S. 1658ISSN: 2234-943XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Circulating tumor cells expressing the prostate specific membrane antigen PSMA indicate worse outcome in triple-negative breast cancer patients at primary diagnosisIn: Cancer Research Jg. 80 (2020) Nr. 4,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Definition and independent validation of a proteomic-classifier in ovarian cancerIn: Cancers Jg. 12 (2020) Nr. 9, S. 2519ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access)
-
High serum levels of periostin are associated with a poor survival in breast cancerIn: Breast Cancer Research and Treatment Jg. 180 (2020) Nr. 2, S. 515 - 524ISSN: 1573-7217; 0167-6806Online Volltext: dx.doi.org/
-
Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors : On the Way to Blood-Based Biomarkers for ImmunotherapiesIn: Breast Care Jg. 15 (2020) Nr. 5, S. 470 - 480ISSN: 1661-3791; 1661-3805Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Localization of PD-L1 on single cancer cells by iSERS microscopy with Au/Au core/satellite nanoparticlesIn: Journal of Biophotonics Jg. 13 (2020) Nr. 3, S. e201960034ISSN: 1864-0648; 1864-063XOnline Volltext: dx.doi.org/ (Open Access)
-
Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple-negative breast cancer patientsIn: Journal of Cellular and Molecular Medicine Jg. 24 (2020) Nr. 15, S. 8405 - 8416ISSN: 1582-1838; 1582-4934Online Volltext: dx.doi.org/ (Open Access)
-
Multimodal targeted deep sequencing of circulating tumor cells and matched cell-free DNA provides a more comprehensive tool to identify therapeutic targets in metastatic breast cancer patientsIn: Cancers Jg. 12 (2020) Nr. 5,ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patientsIn: Cellular and Molecular Life Sciences - CMLS Jg. 77 (2020) Nr. 3, S. 497 - 509ISSN: 1420-682X; 1420-9071Online Volltext: dx.doi.org/ (Open Access)
-
The combined blood analysis of cell-free DNA and genomic DNA of circulating tumor cells reveals additive value in hormone receptor-positive, HER2-negative metastatic breast cancer patientsIn: Cancer Research Jg. 80 (2020) Nr. 4,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast CancerIn: Cancers Jg. 11 (2019) Nr. 2, S. 238ISSN: 2072-6694Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Development and Validation of Multiplex Liquid Bead Array Assay for the Simultaneous Expression of 14 Genes in Circulating Tumor CellsIn: Analytical Chemistry Jg. 91 (2019) Nr. 5, S. 3443 - 3451ISSN: 1520-6882; 0003-2700Online Volltext: dx.doi.org/
-
Digital immune-related gene expression signatures in high-grade serous ovarian carcinoma : Developing prediction models for platinum responseIn: Cancer Management and Research Jg. 11 (2019) S. 9571 - 9583ISSN: 1179-1322Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancerIn: BMC Cancer Jg. 19 (2019) Nr. 1, S. 120ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access)
-
Extracellular vesicle-associated miRNAs in ovarian cancer - design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistanceIn: Clinical Chemistry and Laboratory Medicine Jg. 57 (2019) Nr. 7, S. 1053 - 1062ISSN: 1437-4331; 1434-6621Online Volltext: dx.doi.org/
-
HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancerIn: Scientific Reports Jg. 9 (2019) Nr. 1, S. 5407ISSN: 2045-2322Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
High circulating levels of Periostin are associated with a poor survival in primary, non-metastatic breast cancer patientsIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 4,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
In primary, non-metastatic breast cancer patients, increased serum levels of RANKL significantly correlate with tumor cell spread to the bone and the occurrence of bone metastasis whereas high levels of its soluble decoy receptor osteoprotegerin predict poor survivalIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 4,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
International pooled analysis of the prognostic impact of disseminated tumor cells from the bone marrow in early breast cancer : Results from the PADDY studyIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 4,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Liquid biopsy in ovarian cancer : the potential of circulating miRNAs and exosomesIn: Translational Research Jg. 205 (2019) S. 77 - 91ISSN: 1878-1810; 1931-5244Online Volltext: dx.doi.org/
-
Prognostic significance of PD-1 and PD-L1 positive tumor-infiltrating immune cells in ovarian carcinomaIn: International Journal of Gynecological Cancer Jg. 29 (2019) Nr. 9, S. 1389 - 1395ISSN: 1525-1438; 1048-891XOnline Volltext: dx.doi.org/
-
Prognostic value of RANKL/OPG serum levels and disseminated tumor cells in nonmetastatic breast cancerIn: Clinical Cancer Research Jg. 25 (2019) Nr. 4, S. 1369 - 1378ISSN: 1557-3265; 1078-0432Online Volltext: dx.doi.org/
-
Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian CancerIn: Frontiers in Oncology Jg. 9 (2019)ISSN: 2234-943XOnline Volltext: dx.doi.org/ (Open Access)
-
The analysis of cell-free DNA and circulating tumor cells from one blood tube might empower treatment decisions in metastatic breast cancer patientsIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 4,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancerIn: Scientific Reports Jg. 9 (2019) Nr. 1, S. 2318ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access)
-
Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian CancerIn: Cancers Jg. 11 (2019) Nr. 8, S. 1106ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access)
-
Zirkulierende Tumorzellen und was sie beinhalten : Sind »Liquid Biopsies« die Zukunft?In: Chirurgische Praxis Jg. 86 (2019) Nr. 1, S. 125 - 134ISSN: 0009-4846
-
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancerIn: Gynecologic Oncology Jg. 150 (2018) Nr. 2, S. 355 - 360ISSN: 0090-8258; 1095-6859Online Volltext: dx.doi.org/
-
Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapyIn: OncoImmunology Jg. 7 (2018) Nr. 1,ISSN: 2162-402X; 2162-4011Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancerIn: BMC Cancer Jg. 18 (2018) S. 541ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access)
-
Liquid biopsy in ovarian cancer : Recent advances on circulating tumor cells and circulating tumor DNAIn: Clinical Chemistry and Laboratory Medicine Jg. 56 (2018) Nr. 2, S. 186 - 197ISSN: 1437-4331; 1434-6621Online Volltext: dx.doi.org/ (Open Access)
-
RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patientsIn: Clinical Chemistry Jg. 64 (2018) Nr. 7, S. 1054 - 1062ISSN: 0009-9147; 1530-8561Online Volltext: dx.doi.org/ (Open Access)
-
The association of soluble HLA-G levels and 3 untranslated region haplotypes of the HLA-G gene with the clinical profile of epithelial ovarian cancer patients regarding disease stage, circulating tumor cells and overall survivalIn: Human Leukocyte Antigens Jg. 91 (2018) Nr. 5, S. 467 - 467ISSN: 2059-2302
-
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancerIn: Breast Cancer Research and Treatment Jg. 172 (2018) Nr. 1, S. 93 - 104ISSN: 1573-7217; 0167-6806Online Volltext: dx.doi.org/
-
Zirkulierende Tumorzellen und was sie beinhalten : Sind »Liquid Biopsies« die Zukunft?In: Pädiatrische Praxis Jg. 91 (2018) Nr. 1, S. 15 - 24ISSN: 2198-1698; 0030-9346
-
Zirkulierende Tumorzellen und was sie beinhalten : Sind »Liquid Biopsies« die Zukunft?In: Gynäkologische Praxis Jg. 44 (2018) Nr. 1, S. 75 - 84ISSN: 0341-8677
-
Circulating tumor cells in triple-negative breast cancer patients express prostate related genes and show different genetic profiles in US and German patient cohortsIn: Cancer Research Jg. 77 (2017) Nr. 4,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Clinical relevance of serum HER2 and circulating tumor cell detection in metastatic breast cancer patientsIn: Anticancer Research Jg. 37 (2017) Nr. 6, S. 3117 - 3128ISSN: 1791-7530; 0250-7005Online Volltext: dx.doi.org/
-
Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patientsIn: Cancer Research Jg. 77 (2017) Nr. 4, S. P1 - 01ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancerIn: Molecular Medicine Reports Jg. 15 (2017) Nr. 5, S. 2957 - 2968ISSN: 1791-2997; 1791-3004Online Volltext: dx.doi.org/ (Open Access)
-
Development of a novel HER2 testing strategy, using image-based cell-sorting to isolate pure cell populations from FFPE upstream of FISHIn: Cancer Research Jg. 77 (2017) Nr. 4, S. P5 - 03ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
EMT-like circulating tumor cells in ovarian cancer patients are enriched by platinum-based chemotherapyIn: OncoTarget Jg. 8 (2017) Nr. 30, S. 48820 - 48831ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancerIn: OncoTarget Jg. 8 (2017) Nr. 15, S. 24303 - 24313ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer.In: Scientific Reports Jg. 7 (2017) Nr. 1, S. 17307ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access)
-
Fast and reproducible iSERS microscopy of single HER2-positive breast cancer cells using gold nanostars as SERS nanotags.In: Faraday Discussions Jg. 2015 (2017) S. 377 - 386ISSN: 1359-6640; 1364-5498; 0301-7249Online Volltext: dx.doi.org/
-
Gene expression signatures in circulating tumor cells correlate with response to therapy in metastatic breast cancerIn: Clinical Chemistry Jg. 63 (2017) Nr. 10, S. 1585 - 1593ISSN: 1530-8561; 0009-9147Online Volltext: dx.doi.org/
-
RASSF1A promoter methylation in high-grade serous ovarian cancer : A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNAIn: OncoTarget Jg. 8 (2017) Nr. 13, S. 21429 - 21443ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrowIn: Cancer Research Jg. 77 (2017) Nr. 4,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Therapeutic antibody targeting tumor- and osteoblastic niche-derived jagged1 sensitizes bone metastasis to chemotherapyIn: Cancer cell Jg. 32 (2017) Nr. 6, S. 731 - 747, e1-e6ISSN: 1535-6108; 1878-3686Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer : Do stem cell like cells predict prognosis?In: OncoTarget Jg. 7 (2016) Nr. 18, S. 26454 - 26464ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Breast cancer-derived extracellular vesicles : clinical and prognostic impactIn: Cancer Research Jg. 76 (2016) Nr. 14 Suppl., S. 3152ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Circulating tumor cells in triple-negative and non-triple negative breast cancer patients show different genetic profilesIn: Cancer Research Jg. 76 (2016) Nr. 4 Suppl., P2-02-05ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patientsIn: BMC Cancer Jg. 16 (2016) Nr. 1, S. 522ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access)
-
Detection of circulating trophoblast particles in maternal blood using density gradient centrifugation in preeclampsia and in normotensive pregnanciesIn: Hypertension in Pregnancy Jg. 35 (2016) Nr. 3, S. 323 - 329ISSN: 1064-1955; 1525-6065Online Volltext: dx.doi.org/
-
Different prognostic value of circulating and disseminated tumor cells in primary breast cancer : Influence of bisphosphonate intake?In: Scientific Reports Jg. 6 (2016) S. 26355ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access)
-
Do disseminated tumor cells with stem cell character after therapy predict prognosis in primary ovarian cancerIn: Cancer Research Jg. 76 (2016) Nr. 14 Suppl., S. 2492ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Does primary neoadjuvant systemic therapy eradicate minimal residual disease? : Analysis of disseminated and circulating tumor cells before and after therapyIn: Breast Cancer Research Jg. 18 (2016)ISSN: 1465-542X; 1465-5411Online Volltext: dx.doi.org/ (Open Access)
-
Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatmentIn: OncoTarget Jg. 7 (2016) Nr. 27, S. 41677 - 41690ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access)
-
Evaluation of a novel ELISA for the tumor-associated antigen CA 72-4 in patients with ovarian cancerIn: Future Science OA Jg. 2 (2016) Nr. 4, S. FSO145ISSN: 2053-0846; 2053-0854Online Volltext: dx.doi.org/ (Open Access)
-
Gene expression signatures in circulating tumor cells are prognostic for metastatic lesions in breast cancer patients and correlate with response to therapyIn: Cancer Research Jg. 76 (2016) Nr. 14 Suppl., S. 502ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
In primary breast cancer patients with HER2-negative tumors, HER2-positive circulating tumor cells with stem cell character predict worse outcomeIn: Cancer Research Jg. 76 (2016) Nr. 4 Suppl., P2-02-01ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Serum concentrations of soluble B7-H4 in early pregnancy are elevated in women with preterm premature rupture of fetal membranesIn: American Journal of Reproductive Medicine Jg. 76 (2016) Nr. 2, S. 149 - 154ISSN: 1046-7408Online Volltext: dx.doi.org/
-
The co-stimulatory soluble B7-H4 molecule is elevated in early pregnancy in women with premature rupture of fetal membranesIn: Journal of Reproductive Immunology Jg. 115 (2016) S. 67ISSN: 0165-0378Online Volltext: dx.doi.org/
-
The presence and persistence of ERCC1 positive circulating tumor cells predicts worse prognosis in primary ovarian cancer patientsIn: Cancer Research Jg. 76 (2016) Nr. 14 Suppl., S. 447ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patientsIn: Human Immunology Jg. 77 (2016) Nr. 9, S. 791 - 799ISSN: 1879-1166; 0198-8859Online Volltext: dx.doi.org/
-
iSERS microscopy guided by wide field immunofluorescence : analysis of HER2 expression on normal and breast cancer FFPE tissue sectionsIn: The Analyst / Royal Society of Chemistry (RSC) (Hrsg.) Jg. 141 (2016) Nr. 17, S. 5113 - 5119ISSN: 0003-2654; 1364-5528Online Volltext: dx.doi.org/ (Open Access)
-
Association between tumor infiltrating immune cells, circulating tumor cells in blood and disseminated tumor cells in the bone marrow in patients with primary ovarian cancerIn: Cancer Research Jg. 75 (2015) Nr. 15 Suppl.,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Change of anti-Mullerian-hormone levels during follicular phase in PCOS patientsIn: Gynecological Endocrinology Jg. 31 (2015) Nr. 1, S. 26 - 30ISSN: 0951-3590Online Volltext: dx.doi.org/
-
Changes in the Blood Serum Levels of the Costimulatory Soluble B7-H4 Molecule in Pregnant Women During the Peripartal PhaseIn: American Journal of Reproductive Immunology Jg. 74 (2015) Nr. 3, S. 209 - 215ISSN: 1600-0897; 1046-7408; 8755-8920Online Volltext: dx.doi.org/
-
Detection of disseminated tumor cells in bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancerIn: Journal of Cancer Research and Clinical Oncology Jg. 141 (2015) Nr. 1, S. 87 - 92ISSN: 0171-5216; 1432-1335Online Volltext: dx.doi.org/
-
Different prognostic value of circulating and disseminated tumor cells in primary breast cancer : Influence of bisphosphonate intake?In: Cancer Research Jg. 75 (2015) Nr. 9 Suppl.,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum-restistanceIn: International Journal of Gynecological Cancer Jg. 25 (2015) Nr. 9 (Supplement 1), S. 464ISSN: 1525-1438; 1048-891XOnline Volltext: dx.doi.org/
-
Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-upIn: Archives of Gynecology and Obstetrics Jg. 292 (2015) Nr. 5, S. 1117 - 1125ISSN: 0003-9128; 1432-0711; 0170-9925; 0932-0067Online Volltext: dx.doi.org/
-
Expression profiling of circulating tumor cells : A prognostic and predictive biomarker in metastatic breast cancerIn: Cancer Research Jg. 75 (2015) Nr. 15 Suppl.,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Influence of lifestyle factors and tumor cell dissemination in 632 early breast cancer patientsIn: Cancer Research Jg. 75 (2015) Nr. 9 Suppl.,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Maternal serum copeptin, MR-proANP and procalcitonin levels at 11–13 weeks gestation in the prediction of preeclampsiaIn: Archives of Gynecology and Obstetrics Jg. 292 (2015) Nr. 5, S. 1033 - 1042ISSN: 0003-9128; 1432-0711; 0170-9925; 0932-0067Online Volltext: dx.doi.org/
-
Molecular characterization of circulating tumor cells allows stratifying for prognosis in breast cancer patients undergoing neoadjuvant therapyIn: Cancer Research Jg. 75 (2015) Nr. 15 Suppl.,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
SOX17 gene promoter methylation in high-grade serous epithelial ovarian cancerIn: Cancer Research Jg. 75 (2015) Nr. 15 Supplement,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Single nucleotide polymorphisms of the EpCAM-coding gene TACSTD1 in patients with ovarian cancer and their potential translational aspectsIn: Archives of Gynecology and Obstetrics Jg. 292 (2015) Nr. 6, S. 1367 - 1372ISSN: 0003-9128; 1432-0711; 0170-9925; 0932-0067Online Volltext: dx.doi.org/
-
The AdnaCellector, a new fully automated selection for circulating tumor cells in blood of primary and metastatic breast cancer patientsIn: Cancer Research Jg. 75 (2015) Nr. 15 Suppl.,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
The prognostic impact of soluble HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patientsIn: Tissue Antigens Jg. 86 (2015) Nr. 2, S. 81ISSN: 0001-2815; 1399-0039Online Volltext: dx.doi.org/
-
A fully automated q-PCR-based circulating tumor cell analysis using the Alere TM q-Analyzer test platformIn: Cancer Research Jg. 74 (2014) Nr. Suppl. 19, S. 3076ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Anti-Mullerian Hormone : an indicator for the severity of polycystic ovarian syndromeIn: Archives of Gynecology and Obstetrics Jg. 290 (2014) Nr. 5, S. 1023 - 1030ISSN: 0003-9128; 1432-0711; 0170-9925; 0932-0067Online Volltext: dx.doi.org/
-
Circulating U2 Small Nuclear RNA Fragments as a Novel Diagnostic Tool for Patients with Epithelial Ovarian CancerIn: Clinical Chemistry Jg. 60 (2014) Nr. 1, S. 206 - 213ISSN: 1530-8561Online Volltext: dx.doi.org/
-
Detection of disseminated tumor cells in the bone marrow and circulating tumor cells in blood of patients with early-stage male breast cancerIn: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. e22032ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum ResistanceIn: Clinical Chemistry Jg. 60 (2014) Nr. 10, S. 1282 - 1289ISSN: 0009-9147; 1530-8561Online Volltext: dx.doi.org/
-
Establishment of a new method for the selection and detection of circulating tumor cells in metastatic breast cancer patientsIn: Cancer Research Jg. 74 (2014) Nr. 19 Suppl.,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Explorative investigation of vascular endothelial growth factor receptor expression in primary ovarian cancer and its clinical relevanceIn: Gynecologic Oncology Jg. 133 (2014) Nr. 3, S. 467 - 472ISSN: 1095-6859Online Volltext: dx.doi.org/
-
High throughput few and single cell expression profiling and the characterization of circulating tumor cellsIn: Anticancer Research Jg. 34 (2014) Nr. 10, S. 6014ISSN: 0250-7005
-
Intraindividual right-left comparison of sonographic features in polycystic ovary syndrome (PCOS) diagnosisIn: European Journal of Obstetrics & Gynecology and Reproductive Biology Jg. 181 (2014) S. 124 - 129ISSN: 1872-7654; 0301-2115Online Volltext: dx.doi.org/
-
Predictive markers for the FSH sensitivity of women with polycystic ovarian syndromeIn: Human Reproduction Jg. 29 (2014) Nr. 3, S. 518 - 524ISSN: 1460-2350Online Volltext: dx.doi.org/
-
Serum concentrations of afamin are elevated in patients with polycystic ovary syndromeIn: Endocrine Connections Jg. 3 (2014) Nr. 3, S. 120 - 126ISSN: 2049-3614Online Volltext: dx.doi.org/ (Open Access)
-
Single nucleotide polymorphism of the EpCAM-coding gene TACSTD1 in patients with ovarian cancer and their potential implications in clinical practiceIn: Journal of Clinical Oncology (JCO) Jg. 32 (2014) Nr. 15 Suppl., S. e16515ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Anti-Mullerian-hormone levels during pregnancy and postpartumIn: Reproductive Biology and Endocrinology Jg. 11 (2013) Nr. 1,ISSN: 1477-7827Online Volltext: dx.doi.org/
-
Circulating tumor cells in breast cancerIn: Clinica Chimica Acta Jg. 423 (2013) S. 39 - 45ISSN: 0009-8981; 1873-3492Online Volltext: dx.doi.org/
-
Clinical relevance of VEGF-receptor status in primary ovarian cancer : A pilot study for future biomarker analysesIn: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 15, Suppl., S. 5556ISSN: 0732-183X; 1527-7755
-
Comparison of three molecular assays for the detection and molecular characterization of circulating tumor cells in breast cancerIn: Breast Cancer Research Jg. 15 (2013) Nr. 2,ISSN: 1465-542X; 1465-5411Online Volltext: dx.doi.org/ (Open Access)
-
Establishment of a multimarker gene panel for the characterization of circulating tumor cells in metastatic breast cancerIn: Cancer Research Jg. 73 (2013) Nr. 8 Suppl.,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Evaluation and correlation of risk recurrence in early breast cancer assessed by Oncotype DX, clinicopathological markers and tumor cell dissemination in the blood and bone marrowIn: Molecular and Clinical Oncology Jg. 1 (2013) Nr. 6, S. 1049 - 1054ISSN: 2049-9450; 2049-9469Online Volltext: dx.doi.org/
-
Evaluation of risk recurrence in early breast cancer assessed by Oncotype DX and tumor cell dissemination to blood and bone marrowIn: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. Suppl. 15, S. e11516ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancerIn: International Journal of Gynecological Cancer Jg. 23 (2013) Nr. 5, S. 839 - 845ISSN: 1525-1438; 1048-891XOnline Volltext: dx.doi.org/
-
Serum mass spectrometry analysis in primary ovarian cancer (OC) treated with surgery and adjuvant chemotherapy (CT)In: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. Suppl. 15,ISSN: 0732-183X; 1527-7755
-
The persistence of ERCC1-positive circulating tumor cells predicts worse prognosis in patients with primary ovarian cancerIn: Cancer Research Jg. 73 (2013) Nr. Suppl. 8,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Utility of mesothelin, L1CAM and afamin as biomarkers in primary ovarian cancerIn: Anticancer Research Jg. 33 (2013) Nr. 1, S. 329 - 336ISSN: 0250-7005
-
Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancerIn: Oncology Reports Jg. 30 (2013) Nr. 1, S. 441 - 447ISSN: 1021-335XOnline Volltext: dx.doi.org/
-
Detection of disseminated tumor cells in bone marrow as an independent prognostic factor in primary ovarian cancer patientsIn: Journal of Clinical Oncology Jg. 30 (2012) Nr. 15, Suppl.,ISSN: 0732-183X; 1527-7755
-
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cellsIn: Breast Cancer Research Jg. 14 (2012) Nr. 1,ISSN: 1465-542X; 1465-5411Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survivalIn: BMC Cancer Jg. 12 (2012) S. 325ISSN: 1471-2407Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
MicroRNA and the pathogenesis of ovarian cancer – a new horizon for molecular diagnostics and treatment?In: Clinical Chemistry and Laboratory Medicine Jg. 50 (2012) Nr. 4, S. 601 - 615ISSN: 1437-4331Online Volltext: dx.doi.org/
-
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: The DETECT studyIn: Breast Cancer Research Jg. 14 (2012) Nr. 4,ISSN: 1465-542X; 1465-5411Online Volltext: dx.doi.org/ (Open Access)
-
Schlafende Tumorzellen : Widerstandskämpfer der gynäkologischen TumorerkrankungenIn: Unikate: Berichte aus Forschung und Lehre (2012) Nr. 42: Translationale Krebsforschung: Auf dem Weg zu neuen Therapien, S. 80 - 89ISBN: 978-3-934359-42-0 ISSN: 0944-6060; 1869-3881Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Serum HER2 in the context of circulating tumor cells in patients with metastatic breast cancerIn: Journal of Clinical Oncology Jg. 30 (2012) Nr. 15, Suppl., S. 10599ISSN: 0732-183X; 1527-7755
-
Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progressionIn: BMC Cancer Jg. 11 (2011) S. 4ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access)
-
Circulating 20S proteasome in patients with non-metastasized breast cancerIn: Anticancer Research Jg. 31 (2011) Nr. 6, S. 2197 - 2201ISSN: 0250-7005(Open Access)
-
Comparison of PIK3CA Hot Spot Mutations in the Primary Tumor or Metastases with PIK3CA Mutations or PIK3CA Over-Expression in Circulating Tumor Cells of Metastatic Breast Cancer Patients under Sequential Palliative TherapyIn: Cancer Research Jg. 71 (2011) Nr. Suppl. 24,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patientsIn: Gynecologic Oncology Jg. 122 (2011) Nr. 2, S. 356 - 360ISSN: 0090-8258; 1095-6859Online Volltext: dx.doi.org/
-
Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer : A pilot studyIn: Anticancer Research Jg. 31 (2011) Nr. 10, S. 3623 - 3628ISSN: 1791-7530
-
EpCAM-autoantibody levels in the course of disease of ovarian cancer patientsIn: Medical Oncology Jg. 28 (2011) Nr. 2, S. 626 - 630ISSN: 1559-131X; 1357-0560Online Volltext: dx.doi.org/
-
Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patientsIn: International Journal of Cancer Jg. 128 (2011) Nr. 11, S. 2572 - 2580ISSN: 0020-7136; 1097-0215Online Volltext: dx.doi.org/ (Open Access)
-
Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapyIn: Genes, Chromosomes & Cancer Jg. 50 (2011) Nr. 8, S. 598 - 605ISSN: 1045-2257; 1098-2264Online Volltext: dx.doi.org/
-
Molecular Profiling and Prognostic Relevance of Circulating Tumor Cells in the Blood of Ovarian Cancer Patients at Primary Diagnosis and After Platinum-Based ChemotherapyIn: International Journal of Gynecological Cancer Jg. 21 (2011) Nr. 5, S. 822 - 830ISSN: 1525-1438; 1048-891XOnline Volltext: dx.doi.org/
-
Prognostic Impact of Circulating Tumor Cells Assessed with the Cell Search Assay and Adna Test Breast in Metastatic Breast Cancer Patients – The DETECT StudyIn: Cancer Research Jg. 71 (2011) Nr. 24,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancerIn: Breast Cancer Research Jg. 13 (2011) Nr. 4,ISSN: 1465-542X; 1465-5411Online Volltext: dx.doi.org/ (Open Access)
-
Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancerIn: Molecular Oncology Jg. 5 (2011) Nr. 3, S. 281 - 291ISSN: 1878-0261; 1574-7891Online Volltext: dx.doi.org/
-
The prognostic impact of circulating proteasome concentrations in patients with epithelial ovarian cancerIn: Gynecologic Oncology Jg. 120 (2011) Nr. 2, S. 233 - 238ISSN: 0090-8258; 1095-6859Online Volltext: dx.doi.org/
-
Abstract P2-09-33: Validity of Bone Marker Measurements for Monitoring Response to Bisphosphonate (BP) Therapy with Zoledronic Acid (ZOL) in Metastatic Breast Cancer (mBC): Useful or Not?In: Cancer Research Jg. 70 (2010) Nr. 24, S. P2 - 09ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Abstract P3-02-09: Expression of Stem Cell and Epithelial-Mesenchymal Transition Markers in Primary Breast Cancer Patients with Circulating Tumor CellsIn: Cancer Research Jg. 70 (2010) Nr. 24, S. P3 - 02ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Abstract PD02-04: Molecular Profiling of Circulating Tumor Cells in Blood of Metastatic Breast Cancer Patients Indicates Therapy Response and Provides Information on Epithelial Mesenchymal Transition and Tumor Stem Cell MetabolismIn: Cancer Research Jg. 70 (2010) Nr. 24, S. PD02 - 04ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Effect of ibandronate on tumor cells in the bone marrow and in blood in patients with primary breast cancer : A pilot study
IBMS Davos Workshops: Bone Biology & Therapeutics; 14-19 March 2010; Davos, Switzerland,In: Bone: Official Journal of the International Bone and Mineral Society (IBMS) Jg. 46 (2010) Nr. Suppl. 1, S. S38ISSN: 1873-2763; 8756-3282Online Volltext: dx.doi.org/ -
Gene expression profiling in circulating cells (CTCS) of breast carcinoma patientsIn: Annals of Oncology Jg. 21 (2010) S. 49 - 50ISSN: 0923-7534; 1569-8041
-
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trialIn: Breast Cancer Research and Treatment Jg. 124 (2010) Nr. 2, S. 403 - 412ISSN: 1573-7217; 0167-6806Online Volltext: dx.doi.org/
-
Impact of disseminated tumor cells in bone marrow on outcome of patients with primary ovarian cancerIn: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, S. e15545ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
Prospective evaluation of serum HER2 in comparison with HER2 expression on circulating tumor cells in metastatic breast cancer patients as part of the DETECT studyIn: Onkologie / 29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010 Jg. 33 Suppl. 2 (2010) S. 19 - 19ISSN: 0378-584X; 1423-0240
-
Prospective evaluation of serum tissue inhibitor of metalloproteinase-1 (TIMP-1) and carbonic anhydrase IX (CAIX) in correlation to circulating tumor cells in patients with metastatic breast cancerIn: Journal of Clinical Oncology (JCO) Jg. 28 (2010) Nr. Suppl. 15, S. 1153 - 1153ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
The CYP1A1 Ile462Val polymorphism and platinum resistance of epithelial ovarian neoplasmsIn: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics Jg. 18 (2010) Nr. 7, S. 343 - 347ISSN: 1555-3906; 0965-0407Online Volltext: dx.doi.org/
-
Association of the AA genotype of the BCL2 (-938C>A) promoter polymorphism with better survival in ovarian cancerIn: International Journal of Biological Markers Jg. 24 (2009) Nr. 4, S. 223 - 229ISSN: 0393-6155; 1724-6008Online Volltext: dx.doi.org/
-
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancerIn: Breast Cancer Research Jg. 11 (2009) Nr. 5,ISSN: 1465-542X; 1465-5411Online Volltext: dx.doi.org/ (Open Access)
-
The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer.In: Anticancer Research Jg. 29 (2009) Nr. 8, S. 3449 - 3452ISSN: 0250-7005; 1791-7530
-
The haplotype of two FSHR polymorphisms in ovarian cancer : A potential role of ethnology in risk modificationIn: Gynecologic Oncology Jg. 112 (2009) Nr. 3, S. 486 - 489ISSN: 0090-8258; 1095-6859Online Volltext: dx.doi.org/
-
Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancerIn: Gynecologic Oncology Jg. 107 (2007) Nr. 2, S. 331 - 338ISSN: 0090-8258; 1095-6859Online Volltext: dx.doi.org/
-
Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastasesIn: International Journal of Molecular Medicine Jg. 12 (2003) Nr. 6, S. 969 - 975ISSN: 1107-3756; 1791-244X
-
A clustering and mutual information based analysis of the ELIMA study results : The additive value of multi-parametric liquid biopsies, including CTCs, EVs and cfDNA, in metastatic breast cancer
San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas,In: Cancer Research Jg. 81 (2021) Nr. 4, Supplement, S. PS6 - 60ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ -
Dynamics of a multi-parametric liquid biopsy, including CTCs, EVs, and cfDNA, during therapy in metastatic breast cancer patients provide useful insights for therapy management
San Antonio Breast Cancer Virtual Symposium ; December 8-11, 2020; San Antonio, Texas,In: Cancer Research (2021) S. PS2 - 24ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ -
Image-based identification of single circulating tumor cells in ovarian cancer patients for genomic analysisIn: Cancer Research Jg. 81 (2021) Nr. 13,ISSN: 1538-7445; 0008-5472
-
Metastatic breast cancer subgroup specific mRNA profiles of circulating tumor cells and extracellular vesicles
AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, USA,In: Clinical Trials Jg. 80 (2020) Nr. Suppl. 16, S. 5366ISSN: 0008-5472; 1538-7445Online Volltext: dx.doi.org/ -
Establishment of a workflow for analysis of mRNA and gDNA from circulating tumor cells, extracellular vesicles and cell-free DNA from the same blood sample to mirror the genomic and transcriptomic complexity in metastatic breast cancer patientsIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 13,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Workflow evaluation for molecular characterization of single circulating tumor cells in blood samples of patients with gynecological malignanciesIn: Cancer Research Jg. 79 (2019) Nr. Suppl. 13,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Comparison of HER2, estrogen and progesterone receptor expression profiles of primary tumor, synchronous axillary lymph node metastases and circulating tumor cells in early breast cancer patients
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research Jg. 78 (2018) Nr. 4, Supplement, S. PD3 - 02ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ -
ESR1methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancerIn: Cancer Research Jg. 78 (2018) Nr. Suppl. 13,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research Jg. 78 (2018) Nr. 4, Supplement, P2-02-15ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ -
Overexpression of CXCR4 and JUNB in disseminated tumor cells (DTCs) isolated from breast cancer patients before neoadjuvant treatmentIn: Cancer Research Jg. 78 (2018) Nr. Suppl. 13,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ (Open Access)
-
Serum levels of RANKL are increased in primary breast cancer patients in the presence of disseminated tumor cells in the bone marrow
2018 Annual Meeting of the American Society for Bone and Mineral Research Palais des congrès de Montréal in Montréal, Quebéc, Canada September 28 – October 1, 2018,In: Journal of Bone and Mineral Research (JBMR) Jg. 33 (2018) Nr. Suppl. 1, S. 72 - 73ISSN: 0884-0431; 1523-4681 -
Similarities and differences in RNA profiles of circulating tumor cells in breast cancer subtypes : Do we have therapeutic options?
2017 San Antonio Breast Cancer Symposium ; December 5-9, 2017, San Antonio, Texas,In: Cancer Research Jg. 78 (2018) Nr. 4, Supplement, P2-01-06ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/ -
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray (TM)-HER2 FISH workflowIn: Cancer Research Jg. 79 (2018) Nr. Suppl. 13,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Use of unique molecular identifiers to gain insight about the true positive mutations in cfDNA of breast cancer patients for implementation of personalized treatmentIn: Cancer Research Jg. 79 (2018) Nr. Suppl. 13,ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
ERCC1-Expressinf Circulating Tumor Cells as a Potential Diagnostic Tool for Monitoring Platinum-Based Chemotherapy and for Predicting Outcome of Ovarian CancerIn: International Journal of Gynecological Cancer Jg. 27 (2017) Nr. Suppl. 4, S. ESGO7 - 0140ISSN: 1525-1438; 1048-891XOnline Volltext: dx.doi.org/
-
Analysis of disseminated tumor cells before and after platinum-based chemotherapy in primary ovarian cancer : Do stem cell like cells predict prognosis?
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 22ISSN: 1423-0240; 0378-584X; 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Association between tumor infiltrating immune cells and disseminated tumor cells in the bone marrow of patients with primary breast cancer : A ten year follow-upIn: Cancer Research Jg. 76 (2016) Nr. 4 Suppl., P4-04-07ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer
Krebsmedizin heute: präventiv, personalisiert, präzise und partizipativ ; 32. Deutscher Krebskongress ; 24.-27. Februar 2016, Berlin,In: Oncology Research and Treatment Jg. 39 (2016) Nr. Suppl. 1, S. 95 - 96ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
The detection of excision repair cross-complementing rodent repair deficiency, complementation group 1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum-resistance
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin,In: Oncology Research and Treatment Jg. 37 (2014) Nr. Suppl. 1, S. 3ISSN: 2296-5262Online Volltext: dx.doi.org/ -
Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patientsIn: Cancer Research Jg. 73 (2013) S. PD6 - 3ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
The role of excision repair cross-complementation 1 enzyme (ERCC1)-positive circulating tumor cells in primary and metastatic breast cancerIn: Cancer Research Jg. 73 (2013) P1-04-13ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
MicroRNA-1246 as a novel candidate for a blood-based biomarker in ovarian cancer patientsIn: Cancer Research Jg. 72 (2012) Nr. 8, Suppl., S. 4132ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Are mesothelin and L1CAM useful biomarkers in primary ovarian cancer patients?In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 15, Suppl., S. e15559ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/
-
CK-19, MAGE-A3, HER-2 and TWIST-1 expression by RT-qPCR in CTCs of primary breast cancer patients after positive immune-magnetic selection using anti-EpCAM and anti-MUC1 magnetic beadsIn: Cancer Research Jg. 71 (2011) Nr. 8, Suppl., S. 4150ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Primary tumor loss of heterozygosity proximal to M6P/IGF2R locus is predictive for the presence and persistence of disseminated tumor cells in the bone marrow of ovarian cancer patientsIn: Cancer Research Jg. 71 (2011) Nr. 8, Suppl., S. 2217ISSN: 1538-7445; 0008-5472Online Volltext: dx.doi.org/
-
Are bisphosphonate ibandronate influence disseminated tumor cells in the bone marrow and circulating blood tumor cells in patients with primary breast cancers? Presentation of a pilot studyIn: Onkologie Jg. 33 (2010) Nr. Suppl.2, S. 38 - 38ISSN: 0378-584X; 1423-0240
-
Comparison of estrogen and Progesterone receptor expression on circulating Tumor cells and the Primary tumor in Patients with metastatic Breast cancer
29. Deutscher Krebskongress. Berlin 24.-27. Februar 2010,In: Onkologie Jg. 33 (2010) Nr. Suppl. 2, S. 212ISSN: 0378-584X; 1423-0240Online Volltext: dx.doi.org/